Evidence map›Paper›PMID 29027934›Full record

ArticleMarine drugs2017

Angiotensin I-Converting Enzyme (ACE) Inhibitory Activity, Antioxidant Properties, Phenolic Content and Amino Acid Profiles of Fucus spiralis L. Protein Hydrolysate Fractions.

Lisete Paiva, Elisabete Lima, Ana Isabel Neto, José Baptista

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 102 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Advanced Processing of Giant Kelp (Antioxidants (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Antioxidant and Antidiabetic Activity of Algae.Life (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Bioactive Hydrolysates fromMolecules (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lisete PaivaBiotechnology Centre of Azores (CBA), University of Azores, 9501-801 Ponta Delgada, Portugal. lisete.s.paiva@uac.pt.
Elisabete LimaBiotechnology Centre of Azores (CBA), University of Azores, 9501-801 Ponta Delgada, Portugal. elisabete.mc.lima@uac.pt.ORCID 0000-0002-6736-8729
Ana Isabel NetoAzorean Biodiversity Group, Centre for Ecology, Evolution and Environmental Changes (CE3C), Department of Biology, University of Azores, 9501-801 Ponta Delgada, Portugal. ana.im.neto@uac.pt.
José BaptistaBiotechnology Centre of Azores (CBA), University of Azores, 9501-801 Ponta Delgada, Portugal. jose.ab.baptista@uac.pt.
Universidade dos Açores · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Food protein-derived hydrolysates with multi-bioactivities such as antihypertensive and antioxidant properties have recently received special attention since both activities can play significant roles in preventing cardiovascular diseases. This study reports, for the first time, the angiotensin I-converting enzyme (ACE)-inhibition and antioxidant properties of ultrafiltrate fractions (UF) with different molecular weight ranges (<1, 1-3 and ≥3 kDa) obtained from

Indexed as

Amino AcidsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsAntioxidantsFree Radical ScavengersFucusMolecular WeightPhenolsProtein HydrolysatesAmino AcidsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsAntioxidantsFree Radical ScavengersPhenolsProtein HydrolysatesACE-inhibitionamino acids compositionantioxidant propertiescardiovascular-healthedible brown algaemarine functional foodspeptide fractionsphlorotanninsprotein enzymatic hydrolysateultrafiltration

Identifiers

PMID29027934
PMCPMC5666419
OpenAlexW2762702810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.